Project CHANGE - Clinical practice oriented cHange solutions towards Active aNd healthy aGEing

Funding Agency:
Pfizer Inc.

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an external review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in practice as outlined in the specific RFP.

The European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) is an initiative launched in 2013 by the European Commission to foster innovation and digital transformation in the field of active and healthy ageing, aiming to strengthen EU research and innovation by bringing together a range of relevant actors at EU, national, and regional levels across different areas to handle specific societal challenges and involve all the innovation chain levels.

It is critical to address the global burden of non-communicable diseases (NCDs) by making trusted, quality health solutions available to every patient, everywhere. Despite significant medical advancements in the prevention and treatment of chronic conditions. NCDs such as cardiovascular disease, chronic pain, urology disorders, and glaucoma continue to be the leading causes of death and disability globally, and affect healthy ageing.

It is our intent to support projects proposing translational approaches, in particular initiatives that improve clinical practice for ageing populations that address the issues of adherence to prescription and medical plans, integrated care, or prevention of functional decline and frailty. The approaches should be based on scientific evidences and use mature technologies/methodologies to improve the clinical outcomes and/or the quality of life of individuals (for instance in terms of Disability-Adjusted Life Years - DALYs). Projects focusing on reducing, identifying, or monitoring risk factors (behavioural, biological, societal…) that increase the chances to develop the conditions are also of interest. Clinical practice oriented solutions for better patient outcomes will be preferred for consideration.

Letter Of Intent (LOI) due date: April 19th 2019 

Agency Website

Eligibility Requirements

Geographic Scope: Europe  

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations; government agencies; Research facilities and other entities with a mission related to healthcare improvement. 



Amount Description

Individual projects requesting up to $200,000 USD will be considered.

Funding Type





Curriculum Development
International Opportunities
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

April 19, 2019